Evaluation of Cardiac Markers in Children Undergoing Hematopoietic Stem Cell Transplantation

Journal of Clinical Laboratory Analysis

Volumn 29, Issue 4, 2015, Pages 259-262

  Ozturk, Gulfer ^a   Tavil, Betul ^b   Ozguner, Meltem ^c   Ginis, Zeynep ^a   Erden, Gonul ^a   Tunc, Bahattin ^c   Azik, M Fatih ^c   Uckan, Duygu ^b   Delibas, Namik ^a  

^a Department of Biochemistry Diskapi Yildirim Beyazit Education and Research Hospital ^*  (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ANKARA ONCOLOGY HOSPITAL   (Turkey)

Author keywords

Chemotherapy; Children; Glycogen phosphorylase BB; H FABP; HsCRP

Indexed keywords

BIOLOGICAL MARKER; BUSULFAN; CARBOPLATIN; CREATINE KINASE MB; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETOPOSIDE; FATTY ACID BINDING PROTEIN; FLUDARABINE; GLYCOGEN PHOSPHORYLASE BB; HIGH SENSITIVE C REACTIVE PROTEIN; MELPHALAN; METHOTREXATE; MYOGLOBIN; THYMOCYTE ANTIBODY; TROPONIN I; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD SAMPLING; CARDIOTOXICITY; CELL COUNT; CHILD; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEBRILE NEUTROPENIA; FEMALE; HEART EJECTION FRACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMORRHAGIC CYSTITIS; HUMAN; MALE; ORAL MUCOSITIS; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; THERAPY EFFECT; VEIN OCCLUSION; WHOLE BODY RADIATION; ADOLESCENT; CARDIAC MUSCLE; INFANT; METABOLISM; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; BIOMARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; MYOCARDIUM; YOUNG ADULT;

EID: 84937162611     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21760     Document Type: Article

References (16)

1. Tichelli A, Bhatia S, Socie G. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation. Br J Haematol 2008;142(1):11-26.
2. Tavil B, Koksal E, Yalcin SS, Uckan D. Pretransplant nutritional habits and clinical outcome in children undergoing hematopoietic stem cell transplant. Exp Clin Transplant 2012;10(1):55-61.
3. Kismet E, Varan A, Ayabakan C, Alehan D, Portakal O, Buyukpamukcu M. Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin. Pediatr Blood Cancer 2004;42(3):220-224.
4. Horacek JM, Vasatova M, Tichy M, Pudil R, Jebavy L, Maly J. The use of cardiac biomarkers in detection of cardiotoxicity associated with conventional and high-dose chemotherapy for acute leukemia. Exp Oncol 2010;32(2):97-99.
5. Masugata H, Senda S, Inukai M, et al. Association between high-sensitivity C-reactive protein and left ventricular diastolic function assessed by echocardiography in patients with cardiovascular risk factors. Tohoku J Exp Med 2011;223(4):263-268.
6. National Cancer Institute CTEP. Common toxicity criteria v2.0. Available at: http://ctep.cancer.gov/reporting/CTC-3test.html. Accessed on March 15, 2013.
7. Rowlings PA, Przepiorka D, Klein JP, et al. IBMTR Severity Index for grading acute graft-versus-host disease: Retrospective comparison with Glucksberg grade. Br J Haematol 1997;97(4):855-864.
8. Pudil R, Vasatova M, Lenco J, et al. Plasma glycogen phosphorylase BB is associated with pulmonary artery wedge pressure and left ventricle mass index in patients with hypertrophic cardiomyopathy. Clin Chem Lab Med 2010;48(8):1193-1195.
9. Burton PB, Hogben CE, Joannou CL, et al. Heart fatty acid binding protein is a novel regulator of cardiac myocyte hypertrophy. Biochem Biophys Res Commun 1994;205(3):1822-1828.
10. Orak M, Ustundag M, Guloglu C, Ozhasenekler A, Alyan O, Kale E. The role of the heart-type fatty acid binding protein in the early diagnosis of acute coronary syndrome and its comparison with troponin I and creatine kinase-MB isoform. Am J Emerg Med 2010;28(8):891-896.
11. Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005;51(5):810-824.
12. Rabitzsch G, Mair J, Lechleitner P, et al. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet 1993;341(8851):1032-1033.
13. Horacek JM, Jebavy L, Ulrychova M, et al. Glycogen phosphorylase BB could be a new biomarker for detection of cardiac toxicity during hematopoietic cell transplantation for hematological malignancies. Bone Marrow Transplant 2010;45(6):1123-1124.
14. Horacek JM, Tichy M, Jebavy L, Pudil R, Ulrychova MJM. Use of multiple biomarkers for evaluation of anthracycline-induced cardiotoxicity in patients with acute myeloid leukemia. Exp Oncol 2008;30(2):157-159.
15. Goud BK, Nayal B, Devi OS, et al. Comparison of microalbuminuria with hs-CRP and low density lipoprotein levels in nondiabetic, nonhypertensive myocardial infarction patients. J Cardiovasc Dis Res 2012;3(4):287-289.
16. Horacek JM, Pudil R, Jebavy L, Tichy M, Zak P, Maly J. Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Exp Oncol 2007;29(4):309-313.